Disciplined Investments, LLC Organon & Co. Transaction History

Disciplined Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$19.27 - $24.63 $192 - $246	10 Added 15.38%	75 $1,000
Q1 2023 May 10, 2023	SELL	$21.42 - $32.08 $214 - $320	-10 Reduced 13.33%	65 $1,000
Q4 2022 Feb 01, 2023	BUY	$23.31 - $28.61 $256 - $314	11 Added 17.19%	75 $2,000
Q3 2022 Nov 03, 2022	SELL	$23.4 - $34.25 $374 - $548	-16 Reduced 20.0%	64 $1,000
Q2 2022 Aug 09, 2022	BUY	$31.66 - $38.9 $348 - $427	11 Added 15.94%	80 $3,000
Q1 2022 Apr 22, 2022	BUY	$30.45 - $39.36 $639 - $826	21 Added 43.75%	69 $2,000
Q2 2021 Aug 02, 2021	BUY	$28.45 - $38.0 $1,365 - $1,824	48 New	48 $1,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.